Cerus Corp. (CERS)
Last updated: 2026-10-21 01:37:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Cerus Corp. (CERS) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.31, with a market capitalization of $439.32M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.38 to $3.47. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$439.32M | |
$2.25 | |
$14.76 | |
$0.55 | |
$2.22 | |
1.29M | |
2.16M | |
-- | |
$3.47 | |
$1.38 | |
-- | |
-- |
Cerus Corp. (CERS) Latest Closing Stock Price
Cerus Corp. (CERS) last closed at $2.22 as of 2026-10-20 23:31:00, unchanged from the previous close of $2.22.
During the latest regular trading session, CERS traded between $0.55 and $14.76, with a volume of 1.29M shares. The closing price was near the lower end and near the middle of its 52-week range.
Cerus Corp. (CERS) 7-Day Stock Price Change
Over the past seven days, Cerus Corp. (CERS) moved from $2.30 to $2.31, representing a gain of 0.22% ($0.01).
The stock traded between $2.12 and $2.33 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 1.89 million shares, up versus the previous seven-day period, indicating higher trading activity.
CERS 52-Week Price Position
Position in Range: 44.3%
CERS is currently trading at $2.31, placing it 44.3% of the way from its 52-week low of $1.38 to its 52-week high of $3.47. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Cerus Corp. (CERS)?
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
Cerus Corp. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 345 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Cerus Corp. (CERS) Stock on MEXC
Eligible investors can buy real shares of Cerus Corp. (CERS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Cerus Corp. (CERS) stock price today?
2.Is CERS stock going up or down today?
3.What is CERS pre-market price?
4.What is CERS after-hours price?
5.Is CERS stock trading now?
6.Where does CERS sit relative to its 52-week high and low?
7.What sector is Cerus Corp. in?
8.What is Cerus Corp.'s market capitalization and where is it listed?
9.How is CERS valued in terms of P/E ratio and EPS?
10.Does Cerus Corp. pay a dividend?
Explore More US Stocks
Search Stocks
CERS Stock Calculator
Estimate the value between CERS shares and USD.
CERS Shares to USD
1.00 CERS shares = 2.305 USD
Calculations are estimates based on the latest available price and are for reference only.


